<?xml version="1.0" encoding="UTF-8"?>
<p id="Par60">
 <list list-type="bullet">
  <list-item>
   <p id="Par61">OS assessed from date of commencement of SRT to the date of death from any cause.</p>
  </list-item>
  <list-item>
   <p id="Par62">PFS assessed from date of commencement of SRT to date of first evidence of progression or death by any cause. Progression is defined as: 
    <list list-type="alpha-lower">
     <list-item>
      <p id="Par63">Clinically symptomatic progression requiring tumour specific palliative intervention e.g. change or cessation of anti-cancer systemic treatment, palliative radiotherapy as determined by treating doctor.</p>
     </list-item>
     <list-item>
      <p id="Par64">Development of new lesions or progression of existing lesions.</p>
     </list-item>
    </list>
   </p>
  </list-item>
  <list-item>
   <p id="Par65">Treatment related toxicity using the NCI Common Terminology for Adverse Events Version 5.0 (CTCAE v5.0).</p>
  </list-item>
 </list>
</p>
